Completed × Interventional × Esophageal Neoplasms × Clear all RAMPART
Phase NA Completed
40 enrolled
OPTIC
Phase 1 Completed
21 enrolled
SKYSCRAPER-08
Phase 3 Completed
461 enrolled 24 charts
Weekly Cisplatin/Irinotecan and Radiotherapy in Patients With Locally Advanced Esophageal Cancer: Phase II Trial
Phase 2 Completed
43 enrolled
PROTECT
Phase 2 Completed
106 enrolled
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Phase 1 Completed
16 enrolled 13 charts
Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea
Phase 2 Completed
30 enrolled
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
Phase 1/2 Completed
23 enrolled
ISCON
Phase NA Completed
22 enrolled
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
Phase 3 Completed
203 enrolled 22 charts
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Phase NA Completed
23 enrolled
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
7 enrolled 14 charts
Esophageal Cancer Multimodal Prehabilitation Study
Phase NA Completed
15 enrolled
Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer
Phase NA Completed
160 enrolled
A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy
Phase NA Completed
272 enrolled
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
Phase 1/2 Completed
51 enrolled 20 charts
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Phase 2 Completed
78 enrolled 14 charts
PERIOP-PC
Phase NA Completed
379 enrolled 15 charts
DELOGAST
Phase NA Completed
258 enrolled
A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)
Phase 1/2 Completed
90 enrolled
A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)
Phase 1/2 Completed
214 enrolled
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Phase 1/2 Completed
19 enrolled
High-flow Nasal Cannula Oxygenation in Sedated Endoscopy for High-risk Obstructive Sleep Apnea Patients
Phase NA Completed
80 enrolled
ARION
Phase 2 Completed
112 enrolled
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
Phase 1/2 Completed
22 enrolled
Evaluations of Alcohol Warning Labels
Phase NA Completed
1,053 enrolled 15 charts
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
Phase 2 Completed
37 enrolled 11 charts
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Phase NA Completed
52 enrolled 8 charts
HARMONI
Phase 4 Completed
87 enrolled
A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Phase 2 Completed
74 enrolled
A Study of Patients Receiving High-Dose Rate Brachytherapy
Phase 2 Completed
43 enrolled 13 charts
NeoResII
Phase NA Completed
202 enrolled
ARC-12
Phase 1 Completed
94 enrolled
EARN
Phase NA Completed
33 enrolled
KEYVIBE-005
Phase 2 Completed
613 enrolled
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Phase 3 Completed
545 enrolled 24 charts
The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients
Phase NA Completed
48 enrolled
P102
Phase 1 Completed
151 enrolled
ColdPlay2
Phase NA Completed
58 enrolled 10 charts
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
Phase 2 Completed
56 enrolled
Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients
Phase 2 Completed
50 enrolled
A Study of CDX-585 in Patients With Advanced Malignancies
Phase 1 Completed
20 enrolled
NASO
Phase NA Completed
1,204 enrolled
PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer
Phase 2 Completed
48 enrolled
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
Phase 2 Completed
35 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
COMBO Endoscopy Oropharyngeal Airway in Sedated Gastrointestinal Endoscopy for Obese Patients
Phase 2 Completed
107 enrolled
ABIMMUNE
Phase 1/2 Completed
54 enrolled
AspECT
Phase 3 Completed
2,557 enrolled 17 charts